Technetium (99mTc) votumumab
From Infogalactic: the planetary knowledge core
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | tumor antigen CTAA16.88 |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 148189-70-2 |
ATC code | V09IA04 (WHO) |
(what is this?) (verify) |
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]
The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[3]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Radiopharmaceuticals
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs